Avanos Medical (AVNS) Total Debt Growth (3y) (2016 - 2026)
Avanos Medical (AVNS) Total Debt Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 26.30% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 4.07% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 6.99% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 0.11% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 2.61% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -0.32% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.42% |
| 10 | Avanos Medical | 1.16 Bn | 1.10 Bn | 94.20 Mn | -22.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.49% |
| Dec 31, 2025 | -24.39% |
| Sep 30, 2025 | -26.03% |
| Jun 30, 2025 | -25.48% |
| Mar 31, 2025 | -24.98% |
| Dec 31, 2024 | 1.19% |
| Sep 30, 2024 | 3.76% |
| Jun 30, 2024 | 2.00% |
| Mar 31, 2024 | 0.30% |
| Dec 31, 2023 | -2.27% |
| Sep 30, 2023 | 2.10% |
| Jun 30, 2023 | -5.52% |
| Mar 31, 2023 | -5.28% |
| Dec 31, 2022 | -2.14% |
| Sep 30, 2022 | 0.81% |
| Jun 30, 2022 | 0.83% |
| Mar 31, 2022 | 0.87% |
| Dec 31, 2021 | -19.34% |
| Sep 30, 2021 | -16.34% |
| Jun 30, 2021 | -12.63% |